{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:40:43Z","timestamp":1780098043207,"version":"3.54.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Endometrial cancer (EC), the most common adenocarcinoma, represents 90% of uterine cancer in women with an increased incidence of occurrence attributed to age, obesity, hypertension, and hypoestrogenism. Being the most common gynecological malignancy in women, it shows a relation with the activation of different components of the renin\u2013angiotensin system (RAS), which is predominantly involved in maintaining blood pressure, salt, water, and aldosterone secretion, thereby playing a significant role in the etiology of hypertension. The components of the RAS, i.e., ACE-I, ACE-II, AT1R, AT2R, and Pro(renin) receptor, are widely expressed in both glandular and stromal cells of the endometrium, with varying levels throughout the different phases of the menstrual cycle. This causes the endometrial RAS to implicate angiogenesis, neovascularization, and cell proliferation. Thus, dysfunctioning of the endometrial RAS could predispose the growth and spread of EC. Interestingly, the increased expression of AngII, AGTR1, and AGTR2 showed advancement in the stages and progression of EC via the prorenin\/ATP6AP2 and AngII\/AGTR1 pathway. Therefore, this review corresponds to unraveling the relationship between the progression and development of endometrial cancer with the dysfunction in the expression of various components associated with RAS in maintaining blood pressure.<\/jats:p>","DOI":"10.3389\/fonc.2023.1235418","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:46:20Z","timestamp":1696509980000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Unraveling the relationship between the renin\u2013angiotensin system and endometrial cancer: a comprehensive review"],"prefix":"10.3389","volume":"13","author":[{"given":"Nihad Ashraf","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena","family":"Elsori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowhar","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Tamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeeba","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niti","family":"Sambyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Azhar","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"B1","first-page":"1496","article-title":"New insights into endometrial cancer","volume-title":"Cancers","author":"Paleari","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1200\/JCO.2016.69.4638","article-title":"Addressing the role of obesity in endometrial cancer risk, prevention, and treatment","volume":"34","author":"Onstad","year":"2016","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3039","article-title":"Lack of estrogen receptor-\u03b1 Is associated with epithelial\u2013mesenchymal transition and PI3K alterations in endometrial carcinomaLow ER-\u03b1 Associates with EMT and PI3K alterations in endometrial carcinoma","volume":"19","author":"Wik","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2019.02.002","article-title":"Endometrial cancer: an overview of pathophysiology, management, and care","volume-title":"Seminars in oncology nursing","author":"Passarello","year":"2019"},{"key":"B5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/PGP.0000000000000585","article-title":"Molecular classification and emerging targeted therapy in endometrial cancer","volume":"39","author":"Yen","year":"2020","journal-title":"Int J Gynecol Pathol: Off J Int Soc Gynecol Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1530\/EC-15-0112","article-title":"Renin\u2013angiotensin system gene polymorphisms and endometrial cancer","volume":"5","author":"Pringle","year":"2016","journal-title":"Endocrine Connections"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000084181","article-title":"Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma","volume":"26","author":"Shibata","year":"2005","journal-title":"Tumor Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-020-0531-3","article-title":"The (pro) renin receptor: a novel biomarker and potential therapeutic target for various cancers","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Commun Signaling"},{"key":"B9","first-page":"2596","article-title":"Targeting the (pro) renin receptor in cancers: from signaling to pathophysiological effects","volume":"146","author":"Ouyang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.3390\/ijms24043814","article-title":"Renin-angiotensin-aldosterone system inhibitors and development of gynecologic cancers: A 23 million individual population-based study","volume":"24","author":"Nguyen","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1821606116","article-title":"Tumor-suppressive signaling in the uterus","volume":"116","author":"Li","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0068-6","article-title":"RAS-targeted therapies: is the undruggable drugged","volume":"19","author":"Moore","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13251","article-title":"The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases","volume":"47","author":"Qaradakhi","year":"2020","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/118843","article-title":"Evaluation of the association between angiotensin converting enzyme insertion\/deletion polymorphism and the risk of endometrial cancer in and characteristics of Polish women","volume":"29","author":"Raba","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.736361","article-title":"The effect of local renin angiotensin system in the common types of cancer","volume":"12","author":"Almutlaq","year":"2021","journal-title":"Front Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms","author":"Santos","year":"2019","journal-title":"Am J Physiol-Heart Circulatory Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2019126118","DOI":"10.1073\/pnas.2019126118","article-title":"Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers","volume":"118","author":"Singh","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/01.CIR.0000081768.13378.BF","article-title":"Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor","volume":"108","author":"Flesch","year":"2003","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-007-0636-6","article-title":"Role of the renin angiotensin system in TNF-\u03b1 and Shiga-toxin-induced tissue factor expression","volume":"23","author":"Nestoridi","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.beem.2018.02.003","article-title":"Novel mechanisms of G-protein-coupled receptors functions: AT1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk","volume":"32","author":"T\u00f3th","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/biom10040649","article-title":"Evolution of angiotensin peptides and peptidomimetics as angiotensin II receptor type 2 (AT2) receptor agonists","volume":"10","author":"Vasile","year":"2020","journal-title":"Biomolecules"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001846","article-title":"Renal injury due to renin\u2013angiotensin\u2013aldosterone system activation of the transforming growth factor-\u03b2 pathway","volume":"70","author":"Wolf","year":"2006","journal-title":"Kidney Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"61262","DOI":"10.18632\/oncotarget.11311","article-title":"TGF-\u03b21 stimulates migration of type II endometrial cancer cells by down-regulating PTEN via activation of SMAD and ERK1\/2 signaling pathways","volume":"7","author":"Xiong","year":"2016","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/cells10071767","article-title":"Renin\u2013angiotensin\u2013aldosterone system and immunomodulation: A state-of-the-art review","volume":"10","author":"Laghlam","year":"2021","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-018-0761-y","article-title":"Chrysin pretreatment improves angiotensin system, cGMP concentration in L-NAME induced hypertensive rats","volume":"34","author":"Veerappan","year":"2019","journal-title":"Indian J Clin Biochem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1530\/EC-16-0082","article-title":"Expression of renin\u2013angiotensin system (RAS) components in endometrial cancer","volume":"6","author":"Delforce","year":"2017","journal-title":"Endocrine Connections"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2702-2","article-title":"(Pro) renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy","volume":"55","author":"Kanda","year":"2012","journal-title":"Diabetologia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00416-0","article-title":"RETRACTED ARTICLE: Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours","volume":"10","author":"Xu","year":"2020","journal-title":"Cell Biosci"},{"key":"B29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.celrep.2018.03.046","article-title":"Machine learning detects pan-cancer ras pathway activation in the cancer genome atlas","volume":"23","author":"Way","year":"2018","journal-title":"Cell Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V132446","article-title":"Variation in the renin angiotensin system throughout the normal menstrual cycle","volume":"13","author":"Chidambaram","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/09513590.2014.958991","article-title":"The evaluation of involvement of angiotensin II, its receptors, and androgen receptor in endometrial cancer","volume":"31","author":"Matysiak","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/cells9061336","article-title":"The network of angiotensin receptors in breast cancer","volume":"9","author":"Acconcia","year":"2020","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.3390\/ijms21083003","article-title":"COVID-19 and RAS: unravelling an unclear relationship","volume":"21","author":"D\u2019ardes","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"100666","DOI":"10.1016\/j.repbio.2022.100666","article-title":"ACE inhibitors on ACE1, ACE2, and TMPRSS2 expression and spheroid attachment on human endometrial Ishikawa cells","volume":"22","author":"Fernando","year":"2022","journal-title":"Reprod Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1080285","article-title":"Physiological and pathological roles of Ang II and Ang-(1-7) in the female reproductive system","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol"},{"key":"B36","article-title":"Determination of drug sensitivity subgroups in endometrial cancer based on renin angiotensin system","volume":"44","author":"T\u00fcrk","year":"2022","journal-title":"Erciyes Med J\/Erciyes Tip Dergisi"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2015.16.3.1123","article-title":"Lack of influence of the ACE1 gene I\/D polymorphism on the formation and growth of benign uterine leiomyoma in Turkish patients","volume":"16","author":"Gultekin","year":"2015","journal-title":"Asian Pacific J Cancer Prev"},{"key":"B38","doi-asserted-by":"publisher","first-page":"104801","DOI":"10.1016\/j.meegid.2021.104801","article-title":"Impact of I\/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients","volume":"91","author":"Verma","year":"2021","journal-title":"Infection Genet Evol"},{"key":"B39","doi-asserted-by":"crossref","first-page":"dmm049229","DOI":"10.1242\/dmm.049229","article-title":"RAS pathway regulation in melanoma","volume":"15","author":"Al Mahi","year":"2022","journal-title":"Dis Models Mech"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioaa211","article-title":"The SARS-CoV-2 receptor, angiotensin-converting enzyme 2, is required for human endometrial stromal cell decidualization","volume":"104","author":"Chadchan","year":"2021","journal-title":"Biol Reprod"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1056\/NEJMc2009226","article-title":"Clinical characteristics of pregnant women with Covid-19 in Wuhan, China","volume":"382","author":"Chen","year":"2020","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.kisu.2021.11.002","article-title":"The renin\u2013angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts","volume":"12","author":"Ferrario","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3562464","article-title":"Mode of delivery and clinical findings in COVID-19 infected pregnant women in Northern Italy","author":"Ferrazzi","year":"2020"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaaa030","article-title":"Potential influence of COVID-19\/ACE2 on the female reproductive system","volume":"26","author":"Jing","year":"2020","journal-title":"Mol Hum Reprod"},{"key":"B46","doi-asserted-by":"publisher","first-page":"101077","DOI":"10.1016\/j.genrep.2021.101077","article-title":"ACE2: At the crossroad of COVID-19 and lung cancer","volume":"23","author":"Gottschalk","year":"2021","journal-title":"Gene Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.02.028","article-title":"Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy","volume":"10","author":"Liu","year":"2020","journal-title":"J Infect"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.180737","article-title":"Renin-and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro) renin receptor: does (pro) renin-(pro) renin receptor interaction actually occur","volume":"58","author":"Batenburg","year":"2011","journal-title":"Hypertension"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8847307","article-title":"ACE2 is a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma: implication for COVID-19","volume":"2021","author":"Niu","year":"2021","journal-title":"J Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.890908","article-title":"Current and emerging prognostic biomarkers in endometrial cancer","volume":"12","author":"Njoku","year":"2022","journal-title":"Front Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.18632\/aging.103100","article-title":"ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B52","first-page":"2022","article-title":"COVID 19 DURING PREGNANCY","volume-title":"The 4 th International scientific and practical conference\u2015Modern research in world science","author":"Venkatrao","year":""},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13145","article-title":"The role of KRAS in endometrial cancer: a mini-review","volume":"39","author":"Sideris","year":"2019","journal-title":"Anticancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-019-09784-7","article-title":"Na+, HCO 3\u2013 cotransporter NBCn1 accelerates breast carcinogenesis","volume":"38","author":"Boedtkjer","year":"2019","journal-title":"Cancer Metastasis Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: A heritable breakupMAX and MYC: A heritable breakup","volume":"72","author":"Casc\u00f3n","year":"2012","journal-title":"Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.127258","article-title":"Soluble form of the (pro) renin receptor generated by intracellular cleavage by furin is secreted in plasma","volume":"53","author":"Cousin","year":"2009","journal-title":"Hypertension"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.16.1.653","article-title":"The Myc\/Max\/Mad network and the transcriptional control of cell behavior","volume":"16","author":"Grandori","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.24.7019","article-title":"Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif","volume":"18","author":"Hurlin","year":"1999","journal-title":"EMBO J"},{"key":"B59","article-title":"Renin, prorenin and the kidney: a new chapter in an old saga","volume":"22","author":"Ichihara","year":"2009","journal-title":"J Nephrol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"587","DOI":"10.18632\/oncotarget.28224","article-title":"Role of the prorenin receptor in endometrial cancer cell growth","volume":"13","author":"Martin","year":"2022","journal-title":"Oncotarget"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000265","article-title":"Renin\/prorenin receptors","volume":"69","author":"Nguyen","year":"2006","journal-title":"Kidney Int"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J Clin Invest"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208927","article-title":"TGF-\u03b2 and epithelial-to-mesenchymal transitions","volume":"24","author":"Zavadil","year":"2005","journal-title":"Oncogene"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047049","article-title":"Angiotensin converting enzyme 2: a double-edged sword","volume":"142","author":"Wang","year":"2020","journal-title":"Circulation"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.12.9.1139","article-title":"Akt as a therapeutic target in cancer","volume":"12","author":"Steelman","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0662","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancerPI3K\/AKT\/mTOR pathway inhibition in endometrial cancer","volume":"18","author":"Slomovitz","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"954","DOI":"10.18632\/oncotarget.652","article-title":"Mutations and deregulation of Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR cascades which alter therapy response","volume":"3","author":"McCubrey","year":"2012","journal-title":"Oncotarget"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.38","article-title":"Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma","volume":"21","author":"Pallar\u00e9s","year":"2008","journal-title":"Modern Pathol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210529","article-title":"Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes","volume":"26","author":"Pollock","year":"2007","journal-title":"Oncogene"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.110","article-title":"FGFR2 alterations in endometrial carcinoma","volume":"24","author":"Gatius","year":"2011","journal-title":"Modern Pathol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2008.19.4.241","article-title":"Hypermethylation of E-cadherin in endometrial carcinoma","volume":"19","author":"Park","year":"2008","journal-title":"J Gynecol Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.3390\/ijms21176073","article-title":"Endometrial cancer as a metabolic disease with dysregulated PI3K signaling: shedding light on novel therapeutic strategies","volume":"21","author":"Kyo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1558202","article-title":"Investigational PI3K\/AKT\/mTOR inhibitors in development for endometrial cancer","volume":"28","author":"Barra","year":"2019","journal-title":"Expert Opin Investigational Drugs"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/cancers12102751","article-title":"Small-molecule inhibitors (SMIs) as an effective therapeutic strategy for endometrial cancer","volume":"12","author":"Megino-Luque","year":"2020","journal-title":"Cancers"},{"key":"B76","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.coph.2015.05.016","article-title":"Drugging PI3K in cancer: refining targets and therapeutic strategies","volume":"23","author":"Yap","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.200900041","article-title":"Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors","volume":"1","author":"Mendes-Pereira","year":"2009","journal-title":"EMBO Mol Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5748-4","article-title":"The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis","volume":"19","author":"Saed","year":"2019","journal-title":"BMC Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1409714","article-title":"Metformin is associated with reduced cell proliferation in human endometrial cancer by inbibiting PI3K\/AKT\/mTOR signaling","volume":"34","author":"Zhao","year":"2018","journal-title":"Gynecol Endocrinol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1235418\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:46:27Z","timestamp":1696509987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1235418\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":79,"alternative-id":["10.3389\/fonc.2023.1235418"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1235418","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"article-number":"1235418"}}